Oaktree’s Labyrinthine Bet on Core Scientific

According to the cryptic scrolls of the Securities and Exchange Commission, Oaktree initiated a new position in Core Scientific during the third quarter. The fund, in its infinite quest for value, purchased 6.4 million shares, their worth estimated at $114.8 million as of September 30. This addition swelled Oaktree’s collection of 13F reportable positions to 62, each a fragment of a larger, unknowable tapestry.




